A Preliminary Trial of Testosterone Replacement for Fatigue in Male Hypogonadic Patients With Advanced Cancer.
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Testosterone cipionate (Primary) ; Testosterone enanthate
- Indications Hypogonadism
- Focus Pharmacodynamics
- 07 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 16 Sep 2011 New source identified and integrated (M.D. Anderson Cancer Center record 2008-0262).